2 hours Lexicon Pharmaceuticals’ (LXRX) “Buy” Rating Reaffirmed at HC WainwrightMarketBeat
HC Wainwright reaffirmed a “buy” rating and set a $10.00 price target on shares of Lexicon Pharmaceuticals in a research note on Thursday.
XHC Wainwright reaffirmed a “buy” rating and set a $10.00 price target on shares of Lexicon Pharmaceuticals in a research note on Thursday.
X